Clazosentan in Aneurysmal Subarachnoid Hemorrhage (CONSCIOUS-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00940095
Recruitment Status : Terminated (Lack of efficacy data from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2))
First Posted : July 15, 2009
Last Update Posted : July 9, 2018
Information provided by (Responsible Party):
Idorsia Pharmaceuticals Ltd.